Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Cancer Prev Res (Phila). 2010 Jan;3(1):35–47. doi: 10.1158/1940-6207.CAPR-09-0096

Figure 4.

Figure 4

Figure 4

Adverse events after randomization. The differences between the groups were assessed using chi-square tests. 4a – Overview of Adverse Events after randomization. 4b – Incidence of specific, more common toxicities by treatment group and severity (mild – grade 1, moderate – grade 2, severe – grade 3, life-threatening – grade 4, lethal – grade 5).